Skip to main content

Kevin Conroy

Equibles does not estimate personal net worth.

Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.

Get ABT alerts

About Kevin Conroy

Kevin Conroy is recorded as Board Member at Abbott Laboratories (ABT) since April 24, 2026. Abbott Laboratories reported in an 8-K filed April 27, 2026 that Kevin Conroy was appointed Board of Directors, effective April 24, 2026. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Robert E. Funck, Jr. (CFO) and 7 others.

“On April 24, 2026, Kevin Conroy was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.”
Abbott Laboratories Form 8-K, filed April 27, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Abbott Laboratories

Recent activity